We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TNL:NYSETravel Leisure Co. Analysis

Data as of 2026-05-05 - not real-time

$63.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Travel + Leisure Co. (TNL) is trading at $63.05, well below its 20‑day ($70.68), 50‑day ($71.21) and 200‑day ($67.00) moving averages, indicating a lingering downtrend. The stock sits just above the calculated support level of $61.24 and faces a wide resistance band near $79.49, while a 14‑day RSI of 36 and a bearish MACD histogram reinforce short‑term weakness. Recent earnings surprised on the upside (+10.5% versus estimates) but guidance missed expectations, prompting a 12.9% share‑price drop and heightened investor caution. Despite a solid dividend yield of 3.86% and a payout ratio under 50%, the balance sheet is strained with $5.9 B of debt against minimal cash and a negative book value per share, suggesting limited margin for error. Forward metrics look attractive – a forward PE of 7.4 and projected EPS of $8.51 point to strong earnings growth, yet a discounted cash‑flow valuation of $38.03 implies the market is pricing in significant risk. High 30‑day volatility (≈55%) and a beta above 1.2 amplify price swings, making the stock vulnerable to broader market sentiment and sector‑specific cycles.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical setup (price below all SMAs, MACD negative)
  • Recent 12.9% price decline after disappointing guidance
  • Elevated volatility and beta increasing downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward earnings growth implied by low forward PE
  • Attractive dividend yield with sustainable payout
  • Potential upside if revenue growth sustains around 3%

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Long‑term demand for travel and leisure experiences
  • Diversified brand portfolio and strategic alliances
  • Dividend yield provides income while the company works to improve its balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin5.83%
P/E Ratio17.6
ROA7.61%
P/B Ratio-4.1
Op. Cash Flow$557.0M
Free Cash Flow$531.1M

Technical Analysis

TrendNeutral
RSI36.1
Support$61.24
Resistance$79.49
MA 20$70.68
MA 50$71.21
MA 200$67.00
MACDBearish
VolumeIncreasing
Fear & Greed Index90.54

Valuation

Fair Value$38.03
Target Price$86.25
Upside/Downside36.80%
GradeOvervalued
TypeBlend
Dividend Yield3.86%

Risk Assessment

Beta1.30
Volatility55.35%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.